Yu Guo

2.2k total citations
67 papers, 843 citations indexed

About

Yu Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yu Guo has authored 67 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yu Guo's work include Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Yu Guo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Yu Guo collaborates with scholars based in China, United States and Hong Kong. Yu Guo's co-authors include Sheng Xu, Qi Pan, Shuang Xia, Xiaowu Dong, Qingtao Hu, Linlin Gao, Yu Zhang, Tao Cai, Zhiyi Jing and Guangqing Lu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Guo

60 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Guo China 18 320 272 169 127 119 67 843
Heng Jiang China 17 419 1.3× 319 1.2× 132 0.8× 251 2.0× 146 1.2× 41 974
Qin Zhao China 16 302 0.9× 240 0.9× 189 1.1× 185 1.5× 129 1.1× 34 934
Haiping Pei China 19 279 0.9× 300 1.1× 97 0.6× 130 1.0× 83 0.7× 38 730
Katarzyna Kulcenty Poland 17 377 1.2× 192 0.7× 92 0.5× 156 1.2× 87 0.7× 48 766
Jie Lan China 17 383 1.2× 254 0.9× 118 0.7× 159 1.3× 82 0.7× 28 962
Rosaria Cammarota Italy 7 285 0.9× 339 1.2× 93 0.6× 102 0.8× 108 0.9× 8 969
Beatriz Arteta Spain 18 480 1.5× 282 1.0× 259 1.5× 121 1.0× 68 0.6× 34 951
Ying Jin China 15 379 1.2× 196 0.7× 80 0.5× 154 1.2× 60 0.5× 37 706
Tejaswitha Jairaj Naik United States 6 561 1.8× 416 1.5× 240 1.4× 158 1.2× 52 0.4× 6 1.4k

Countries citing papers authored by Yu Guo

Since Specialization
Citations

This map shows the geographic impact of Yu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Guo more than expected).

Fields of papers citing papers by Yu Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Guo. The network helps show where Yu Guo may publish in the future.

Co-authorship network of co-authors of Yu Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Guo. A scholar is included among the top collaborators of Yu Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Guo. Yu Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Fangmin, Huijuan Zhang, Shuang Li, et al.. (2025). Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy. Nature Communications. 17(1). 272–272.
3.
Gao, Chuntao, Yu Guo, Di Xiao, et al.. (2025). Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. Gut. 74(9). 1437–1451. 9 indexed citations
4.
Lu, Yang, Peipei Wang, Haifeng Chen, et al.. (2024). Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression. European Journal of Medicinal Chemistry. 272. 116468–116468. 9 indexed citations
5.
Zhang, Jia, Yu Guo, Jiaqi Su, et al.. (2024). The first high-quality genome assembly and annotation of Anthocidaris crassispina. Scientific Data. 11(1). 866–866.
6.
Guo, Sifan, Ying Cai, Qiang Yang, et al.. (2024). Decoding active compounds and molecular targets of herbal medicine by high-throughput metabolomics technology: A systematic review. Bioorganic Chemistry. 144. 107090–107090. 10 indexed citations
7.
Dong, Xiaowu, Yu Guo, Jingyu Zhang, et al.. (2024). Potent in Vitro and In Vivo Efficacy of Hdz-C123A, a GSPT1 Degrader-Antibody Conjugate Targeting CD123 in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 156–156. 2 indexed citations
8.
Guo, Yu, et al.. (2024). Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma. Cancer Biology and Medicine. 21(5). 1–17. 9 indexed citations
9.
Liu, Yujian, Ziqi Deng, Yu Guo, et al.. (2023). Synthesis, Structures, and Chiroptical Properties of NBN-Doped Helicenes with Boron Atoms in the Inner Rims. SHILAP Revista de lepidopterología. 2(1). 28–39. 6 indexed citations
11.
Li, Jiannan, et al.. (2023). The characteristics and medical applications of antler stem cells. Stem Cell Research & Therapy. 14(1). 225–225. 8 indexed citations
12.
Guo, Yu, Lu Yang, Xiuchao Wang, et al.. (2023). Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study. Frontiers in Oncology. 13. 1276037–1276037. 1 indexed citations
13.
Chen, Haihong, et al.. (2022). The role of interleukin 36γ in the epithelial–mesenchymal transition process of chronic rhinosinusitis: A pilot study. Clinical Otolaryngology. 48(2). 347–355. 2 indexed citations
14.
Che, Jinxin, Dan Li, Yu Guo, et al.. (2022). Discovery of new macrophage M2 polarization modulators as multiple sclerosis treatment agents that enable the inflammation microenvironment remodeling. European Journal of Medicinal Chemistry. 243. 114732–114732. 8 indexed citations
15.
Wang, Qianqian, Jinguo Liu, Yu Guo, et al.. (2022). Log P analyzation-based discovery of GSH activated biotin-tagged fluorescence probe for selective colorectal cancer imaging. European Journal of Medicinal Chemistry. 239. 114555–114555. 6 indexed citations
16.
Guo, Yu, et al.. (2022). Epstein–Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report. Frontiers in Oncology. 11. 769310–769310. 2 indexed citations
17.
Zhou, Tianxing, Jing Liu, Yongjie Xie, et al.. (2021). ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Gut. 71(2). 357–371. 33 indexed citations
18.
Hu, Qingtao, Hong Yu, Qi Pan, et al.. (2021). Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nature Communications. 12(1). 2186–2186. 126 indexed citations
19.
Chai, Chao, Mengjie Zhang, Zhiqiang Chu, et al.. (2015). Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis. Metabolic Brain Disease. 30(4). 1009–1016. 26 indexed citations
20.
Kupelian, Anthony, Harry Horsley, Yu Guo, et al.. (2011). A NOVEL FLUORESCENCE TECHNIQUE TO ILLUMINATE BACTERIAL ADHESION TO UROTHELIAL CELLS IN OAB: A RADIANT DEMONSTRATION OF PATHOLOGY IN ACTION. Neurourology and Urodynamics. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026